Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

VEEA vs NIVF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VEEA Captures Overall Composite Edge (47.7 HOLD vs 46.4 HOLD), While NIVF Leads 3–1 on Growth & Valuation Pillars

VEEA Overall Winner 6-Pillar Tally: VEEA 1 – 3 NIVF (2 Tie) Matrix Metrics: VEEA 5 – 3 NIVF

As of Nov 16, 2026, Veea Inc. (VEEA) captures the overall head-to-head institutional edge over NewGenIvf Group Limited Class A (NIVF) on higher Unified Composite conviction (47.7/100 HOLD vs. 46.4/100 HOLD) after splitting the core matrix 5–3 (led by Growth & Scale), while NIVF wins 3–1 across the 6-pillar growth and valuation breakdown. VEEA trades at $4.78 (N/M Forward P/E, -3873.7% operating margin) versus NIVF at $0.20 (N/M Forward P/E, -238.2% operating margin).

  • Growth vs. Quality Trade-Off: VEEA earns the overall head-to-head edge with a stronger Unified Composite Score (47.7/100 HOLD vs. NIVF 46.4/100 HOLD) and -2.32β · 136% Vol risk profile, whereas NIVF leads top-line expansion (-4.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1); meanwhile NIVF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VEEA vs NIVF
VEEA NASDAQ Head-to-Head Winner
Veea Inc. Common Stock
Services-Computer Integrated Systems Design
$4.78
+6.46% 1D
Market Cap $18.3M
TTM Revenue $491,488
Forward P/E N/M
Beta / 30D Vol -2.32β · 136% Vol
Unified Composite Score
47.7 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (67.3% over 20 days), RSI 53
RSI-14: 53.1 · SMA20: $4.73 · SMA50: $4.18
NIVF NASDAQ
NewGenIvf Group Limited Class A ordinary shares
Services-Misc Health & Allied Services, Nec
$0.20
-11.33% 1D
Market Cap $369,508
TTM Revenue $4.6M
Forward P/E N/M
Beta / 30D Vol 0.07β · 3093% Vol
Unified Composite Score
46.4 / 100 HOLD
Tech 50.0 Fund 48.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 38
RSI-14: 38.1 · SMA20: $0.64 · SMA50: $0.54

6-Pillar Scorecard Institutional Category Breakdown (VEEA 1 – 3 NIVF)

Columns: Metric · VEEA · NIVF
1. Valuation Multiples NIVF
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 62.7x 0.1x
2. Growth & Scale VEEA
Revenue Growth (YoY) +141.6% -4.7%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $491,488 $4.6M
Market Cap $18.3M $369,508
3. Profitability & Quality NIVF
Gross Margin 74.3% 23.9%
Operating Margin -3873.7% -238.2%
Net Profit Margin 0.0% 24.2%
Return on Equity (ROE) 0.0% 5.5%
4. Balance Sheet & Cash Flow NIVF
Cash Generation (TTM) -$19M -$11M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $13M Net Debt (1.67x D/E) $733.75 Book/Sh · 5.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Information Technology Services Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VEEA (5) vs NIVF (3)
Institutional Metric VEEA NIVF Criterion Row Edge
Market Capitalization
Scale
$18.3M $369,508 Larger Scale VEEA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+141.6% -4.7% Higher Growth VEEA
Operating Margin (TTM)
Profitability
-3873.7% -238.2% Higher Margin NIVF
Net Profit Margin
Profitability
0.0% 24.2% Higher Margin NIVF
Return on Equity (ROE)
Capital Efficiency
0.0% 5.5% Higher ROE NIVF
52-Week Range Position
Momentum
53% ($0–$9) 5% ($0–$3) Stronger Trend VEEA
Beta / 30D Volatility
Risk Regime
-2.32β · 136% Vol 0.07β · 3093% Vol Lower Realized Risk VEEA
Unified Institutional Score
Composite Signal
47.7 / 100 (HOLD) 46.4 / 100 (HOLD) Higher Composite VEEA
Trailing 12M Revenue (USD)
Operating Scale
$491,488 $4.6M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
74.3% 23.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 62.7x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$19M ($13M Net Debt (1.67x D/E)) -$11M EBITDA ($733.75 Book/Sh · 5.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VEEA +40.06 pp
VEEA: +13.54% · NIVF: -26.52%
3M Horizon VEEA +3404.01 pp
VEEA: +3341.32% · NIVF: -62.69%
6M Horizon VEEA +778.83 pp
VEEA: +701.61% · NIVF: -77.22%
1Y Horizon VEEA +781.23 pp
VEEA: +736.4% · NIVF: -44.83%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VEEA Revenue NIVF Revenue VEEA Op. Margin NIVF Op. Margin Margin Leader
FY2021 N/A $0M N/A 4.8% NIVF
FY2022 N/A $10M N/A 6.7% NIVF
FY2023 $10M $10M -114.2% 0.8% NIVF
FY2024 $0M $10M -59309.8% -21.4% NIVF
FY2025 $0M $0M -8483.7% -226.9% NIVF

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VEEA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VEEA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NIVF UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NIVF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VEEA Moat Profile Cyclical / Execution-Driven Positioning
Information Technology Services Operator
Competes within the Information Technology Services value chain with $18.3M market capitalization and -3873.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
NIVF Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $369,508 market capitalization and -238.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ VEEA vs NIVF Key Questions & Quantitative Answers

As of Nov 16, 2026, Veea Inc. (VEEA) captures the overall head-to-head institutional edge over NewGenIvf Group Limited Class A (NIVF) on higher Unified Composite conviction (47.7/100 HOLD vs. 46.4/100 HOLD) after splitting the core matrix 5–3 (led by Growth & Scale), while NIVF wins 3–1 across the 6-pillar growth and valuation breakdown. VEEA trades at $4.78 (N/M Forward P/E, -3873.7% operating margin) versus NIVF at $0.20 (N/M Forward P/E, -238.2% operating margin). Growth vs. Quality Trade-Off: VEEA earns the overall head-to-head edge with a stronger Unified Composite Score (47.7/100 HOLD vs. NIVF 46.4/100 HOLD) and -2.32β · 136% Vol risk profile, whereas NIVF leads top-line expansion (-4.7% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1); meanwhile NIVF is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VEEA leads the Growth & Scale pillar: VEEA posts +141.6% YoY revenue growth and +0.0% YoY earnings growth on $491,488 TTM revenue (74.3% gross margin, -3873.7% operating margin), compared with NIVF at -4.7% YoY revenue growth and +0.0% YoY earnings growth on $4.6M TTM revenue (23.9% gross margin, -238.2% operating margin). Across the 5-period historical trajectory (FY2021 to FY2025), VEEA cumulative revenue shifted N/A while NIVF shifted +0.0%. In operating R&D and SG&A reinvestment, VEEA deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NIVF.

NIVF screens cheaper on headline valuation multiples. VEEA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 62.7x EV/Revenue (unreported FCF margin), whereas NIVF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VEEA (0.0% ROE) versus NIVF (5.5% ROE) capital efficiency.

In options market volatility and institutional positioning, VEEA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-2.32β · 136% Vol realized risk). By comparison, NIVF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.07β · 3093% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.